| |
|
|
|
Kempharm Inc  
|
|
10.05 0.42 (0.04%) |
03-05 16:00 |
|
Open: |
10.4267 |
Pre close: |
9.63 |
Target:
|
15.72
|
|
High: |
10.4267 |
Low: |
8.21 |
Resistance:
|
13.46
18.15
|
|
Volume: |
5,230,132 |
Market Cap: |
189M |
Support:
|
5.86
4.88
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
10.48
 |
MACD |
MACD(12,26):
|
0.55  |
|
MA(20): |
9.84 |
Signal(12,26,9): |
0.49 |
|
MA(100): |
10.21 |
Stochastic Oscillator |
%K(14,3):
|
29.07 |
|
MA(250): |
7.71 |
%D(3): |
36.51 |
|
Average Volume(K) |
3-Month: |
319712
|
52-Week |
High:
|
22.08 |
|
10-Days: |
1016641 |
Low: |
0.67 |
|
RSI |
RSI(14):
|
52.15 |
Change(%): |
124.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-4.140 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
11.65 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-31.0 |
Shares Float (M) |
3.98 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.12 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-83.2 |
% Held by Institutions |
6.03 |
|
Forward EPS |
0.000 |
Gross Profit (p.s.) |
0.849 |
Shares Short (K) |
408 |
|
Book Value (p.s.) |
-13.750 |
EBITDA (p.s.) |
-0.488 |
P/E |
-2.43 |
|
Sales Per Share |
1.056 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-0.73 |
|
Profit Margin |
-113.36 |
Operating Cash Flow
(M) |
-3.98 |
P/S |
9.52 |
|
Operating Margin |
-48.58 |
Levered Free Cash Flow
(M) |
-1.88 |
P/CF |
-29.42 |
|
|
|
|
|
|
